Robert Hagemann, Director at ZIMMER BIOMET HOLDINGS, INC. (ZBH), bought 2,000 shares at $116.48 ($233K) on 2023-08-28, disclosed to the SEC on 2023-08-30.
Open-market purchase of $233k ZBH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ZBH | BUY | 2019-02-06 | $240K | — | Filing → |
| R | BUY | 2015-02-10 | $216K | — | Filing → |
| GPK | BUY | 2015-02-10 | $180K | — | Filing → |